$ALKS
Alkermes plc.

2022 Q3 Form 10-Q Financial Statement

#000156459022026586 Filed on July 27, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $252.4M $276.2M $278.5M
YoY Change -14.21% -9.05% 10.8%
Cost Of Revenue $50.63M $58.36M $55.16M
YoY Change 2.15% 9.86% 34.53%
Gross Profit $201.7M $217.9M $223.4M
YoY Change -17.52% -13.06% 6.17%
Gross Profit Margin 79.94% 78.87% 80.2%
Selling, General & Admin $152.8M $150.4M $145.1M
YoY Change 12.16% 8.04% 15.86%
% of Gross Profit 75.73% 69.02% 64.93%
Research & Development $100.4M $92.87M $93.15M
YoY Change -15.19% -4.72% 0.92%
% of Gross Profit 49.78% 42.63% 41.7%
Depreciation & Amortization $19.60M $19.39M $19.20M
YoY Change 1.06% 4.71% -2.06%
% of Gross Profit 9.71% 8.9% 8.59%
Operating Expenses $253.2M $243.3M $250.0M
YoY Change -4.18% 2.78% 10.17%
Operating Profit -$60.64M -$34.46M -$26.59M
YoY Change 208.46% -879.39% 61.12%
Interest Expense $3.552M $2.369M -$1.277M
YoY Change -280.4% -1.58% 27.7%
% of Operating Profit
Other Income/Expense, Net -$6.727M $1.207M -$17.14M
YoY Change 34.35% -2.19% -2004.0%
Pretax Income -$67.37M -$33.25M -$45.00M
YoY Change 153.88% -687.98% 140.63%
Income Tax -$3.400M -$3.100M -$9.100M
% Of Pretax Income
Net Earnings -$63.97M -$30.14M -$35.90M
YoY Change 120.69% -1374.79% 60.15%
Net Earnings / Revenue -25.35% -10.91% -12.89%
Basic Earnings Per Share -$0.39 -$0.18 -$0.22
Diluted Earnings Per Share -$0.39 -$0.18 -$221.0K
COMMON SHARES
Basic Shares Outstanding 164.3M 163.8M 162.5M
Diluted Shares Outstanding 164.3M 163.8M 162.5M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $580.2M $581.0M $528.9M
YoY Change 3.55% 7.92% -2.24%
Cash & Equivalents $264.0M $254.6M $282.6M
Short-Term Investments $316.2M $326.3M $246.3M
Other Short-Term Assets $40.04M $47.09M $61.02M
YoY Change -34.72% -17.65% -21.77%
Inventory $166.3M $155.6M $154.8M
Prepaid Expenses
Receivables $267.3M $262.3M $270.2M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.054B $1.046B $1.015B
YoY Change 0.08% 0.79% 0.88%
LONG-TERM ASSETS
Property, Plant & Equipment $326.4M $337.1M $336.7M
YoY Change -4.18% -1.98% -2.77%
Goodwill $92.87M $92.87M $92.87M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $166.9M $179.0M $229.8M
YoY Change -11.14% 36.62% 166.0%
Other Assets $10.98M $11.57M $123.2M
YoY Change -90.75% -90.0% 5.01%
Total Long-Term Assets $888.1M $911.4M $963.0M
YoY Change -5.76% 1.29% 10.41%
TOTAL ASSETS
Total Short-Term Assets $1.054B $1.046B $1.015B
Total Long-Term Assets $888.1M $911.4M $963.0M
Total Assets $1.942B $1.957B $1.978B
YoY Change -2.68% 1.02% 5.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $33.20M $40.05M $27.70M
YoY Change -9.97% 22.1% -23.27%
Accrued Expenses $429.4M $391.7M $426.7M
YoY Change 5.57% 14.86% 33.86%
Deferred Revenue $3.982M $3.787M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.000M $3.000M $3.000M
YoY Change 0.0% 0.0% 0.0%
Total Short-Term Liabilities $469.6M $438.5M $462.4M
YoY Change 3.66% 14.36% 26.4%
LONG-TERM LIABILITIES
Long-Term Debt $290.9M $291.5M $292.2M
YoY Change -0.86% -0.86% -0.86%
Other Long-Term Liabilities $42.86M $45.21M $147.9M
YoY Change -71.96% -72.12% -11.16%
Total Long-Term Liabilities $333.8M $336.7M $440.1M
YoY Change -25.21% -26.19% -4.58%
TOTAL LIABILITIES
Total Short-Term Liabilities $469.6M $438.5M $462.4M
Total Long-Term Liabilities $333.8M $336.7M $440.1M
Total Liabilities $899.0M $875.1M $902.5M
YoY Change -0.02% 4.22% 9.11%
SHAREHOLDERS EQUITY
Retained Earnings -$1.671B -$1.607B
YoY Change
Common Stock $2.887B $2.860B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.043B $1.082B $1.075B
YoY Change
Total Liabilities & Shareholders Equity $1.942B $1.957B $1.978B
YoY Change -2.68% 1.02% 5.31%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$63.97M -$30.14M -$35.90M
YoY Change 120.69% -1374.79% 60.15%
Depreciation, Depletion And Amortization $19.60M $19.39M $19.20M
YoY Change 1.06% 4.71% -2.06%
Cash From Operating Activities $625.0K -$2.306M $21.68M
YoY Change -99.24% -106.98% -148.02%
INVESTING ACTIVITIES
Capital Expenditures -$10.47M -$9.962M $7.791M
YoY Change 117.62% 52.18% -2.44%
Acquisitions
YoY Change
Other Investing Activities $19.37M -$30.58M -$52.85M
YoY Change -172.03% -391.45% 77.95%
Cash From Investing Activities $8.898M -$40.54M -$60.64M
YoY Change -128.06% -1127.58% 60.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $750.0K
YoY Change
Cash From Financing Activities -212.0K 14.93M -16.02M
YoY Change -120.52% -8.49% -207.22%
NET CHANGE
Cash From Operating Activities 625.0K -2.306M 21.68M
Cash From Investing Activities 8.898M -40.54M -60.64M
Cash From Financing Activities -212.0K 14.93M -16.02M
Net Change In Cash 9.311M -27.91M 21.68M
YoY Change -82.13% -152.39% -131.91%
FREE CASH FLOW
Cash From Operating Activities $625.0K -$2.306M $21.68M
Capital Expenditures -$10.47M -$9.962M $7.791M
Free Cash Flow $11.10M $7.656M $13.89M
YoY Change -87.33% -80.65% -126.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 alks Receipt Of Company Stock For Exercise Of Stock Options Or To Satisfy Minimum Tax Withholding Obligations Related To Stock Based Awards Value
ReceiptOfCompanyStockForExerciseOfStockOptionsOrToSatisfyMinimumTaxWithholdingObligationsRelatedToStockBasedAwardsValue
-17069000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
276219000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
303717000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
555147000
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
58360000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
94144000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
92873000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9066000
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
623000
us-gaap Interest Expense
InterestExpense
4719000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-33250000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5655000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12998000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7056000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-30136000
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
163839000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
160817000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
163839000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-79000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-1055000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-253000
us-gaap Profit Loss
ProfitLoss
-66039000
us-gaap Profit Loss
ProfitLoss
-20054000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
38588000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
38119000
us-gaap Share Based Compensation
ShareBasedCompensation
41720000
us-gaap Share Based Compensation
ShareBasedCompensation
43003000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
22194000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
3123000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-40815000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
10806000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-18197000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-5607000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4569000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
11232000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
1986000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-2029000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-29045000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-52629000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
4518000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-171000
us-gaap Other Noncash Expense
OtherNoncashExpense
637000
us-gaap Other Noncash Expense
OtherNoncashExpense
1302000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-67382000
alks Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
-8331000
alks Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
-8595000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4071000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3108000
alks Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-8911000
alks Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-7821000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
3076000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-159000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
19372000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12083000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17753000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14546000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
177000
alks Proceeds From Contingent Consideration
ProceedsFromContingentConsideration
1043000
alks Proceeds From Contingent Consideration
ProceedsFromContingentConsideration
7889000
alks Return Of Investments
ReturnOfInvestments
485000
alks Payment Made For Licensed Intellectual Property
PaymentMadeForLicensedIntellectualProperty
1000000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
194879000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
201774000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
109925000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
175499000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-101179000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-33755000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
17992000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
20498000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
17583000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
11120000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
23567000
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
977000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1500000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
750000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1091000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
31218000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-82898000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14620000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
337544000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
272961000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
254646000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
258341000
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
4863000
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
1023000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1112584000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1795000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23641000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
326000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2254000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-30136000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1066982000
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2053000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18494000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-1382000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4511000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-35903000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1075390000
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
16197000
CY2022Q2 alks Receipt Of Company Stock For Exercise Of Stock Options Or To Satisfy Minimum Tax Withholding Obligations Related To Stock Based Awards Value
ReceiptOfCompanyStockForExerciseOfStockOptionsOrToSatisfyMinimumTaxWithholdingObligationsRelatedToStockBasedAwardsValue
-514000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1082324000
CY2021Q1 alks Receipt Of Company Stock For Exercise Of Stock Options Or To Satisfy Minimum Tax Withholding Obligations Related To Stock Based Awards Value
ReceiptOfCompanyStockForExerciseOfStockOptionsOrToSatisfyMinimumTaxWithholdingObligationsRelatedToStockBasedAwardsValue
-10413000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15552000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-174000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-601000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-22418000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1051155000
CY2021Q2 alks Receipt Of Company Stock For Exercise Of Stock Options Or To Satisfy Minimum Tax Withholding Obligations Related To Stock Based Awards Value
ReceiptOfCompanyStockForExerciseOfStockOptionsOrToSatisfyMinimumTaxWithholdingObligationsRelatedToStockBasedAwardsValue
-707000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26917000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-272000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
2364000
us-gaap Nature Of Operations
NatureOfOperations
<p id="N1_COMPANY" style="margin-top:10pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1. THE COMPANY</p> <p style="margin-top:10pt;margin-bottom:0pt;text-indent:2.71%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Alkermes plc is a fully-integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to research, develop and commercialize, both with partners and on its own, pharmaceutical products that are designed to address unmet medical needs of patients in the fields of neuroscience and oncology. Alkermes has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, the Company has a research and development (“R&amp;D”) center in Waltham, Massachusetts; an R&amp;D and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio.</p>
CY2022Q2 alks Long Term Investment Amortized Cost
LongTermInvestmentAmortizedCost
184845000
CY2021Q4 alks Marketable Investments Securities Unrealized Gain Loss
MarketableInvestmentsSecuritiesUnrealizedGainLoss
287000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Reclassification</p> <p style="margin-top:10pt;margin-bottom:0pt;text-indent:2.71%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company reclassified certain prior year amounts on the condensed consolidated balance sheet to conform to the current year presentation. These reclassifications had no impact on the previously reported total assets, liabilities or shareholders’ equity.</p>
CY2021Q4 alks Marketable Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
MarketableSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
1497000
CY2021Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
428197000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:10pt;margin-bottom:0pt;text-indent:2.71%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the Company’s condensed consolidated financial statements in accordance with GAAP requires that Company management make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates, judgments and methodologies, including, but not limited to, those related to revenue from contracts with its customers and related allowances, impairment and amortization of intangibles and long-lived assets, share-based compensation, income taxes including the valuation allowance for deferred tax assets, valuation of investments, contingent consideration and litigation. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different conditions or using different assumptions.</p>
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
13363000
us-gaap Contract With Customer Asset Purchase
ContractWithCustomerAssetPurchase
21883000
us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
18760000
CY2022Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
16486000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
17830000
alks Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
829000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-4900000
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
13759000
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
229430000
CY2021Q4 alks Marketable Securities At Amortized Cost
MarketableSecuritiesAtAmortizedCost
429407000
CY2022Q2 alks Long Term Investment Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
LongTermInvestmentSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
5563000
CY2022Q2 alks Long Term Investment Securities Continuous Unrealized Loss Position More Than12 Months Aggregate Losses
LongTermInvestmentSecuritiesContinuousUnrealizedLossPositionMoreThan12MonthsAggregateLosses
272000
CY2022Q2 us-gaap Long Term Investments
LongTermInvestments
179010000
CY2022Q2 alks Marketable Securities At Amortized Cost
MarketableSecuritiesAtAmortizedCost
514360000
CY2022Q2 alks Marketable Investments Securities Unrealized Gain Loss
MarketableInvestmentsSecuritiesUnrealizedGainLoss
26000
CY2022Q2 alks Marketable Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
MarketableSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
8720000
CY2022Q2 alks Marketable Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses
MarketableSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses
335000
CY2022Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
505331000
CY2021Q4 alks Long Term Investment Amortized Cost
LongTermInvestmentAmortizedCost
230811000
CY2021Q4 alks Long Term Investment Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
LongTermInvestmentSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
1381000
CY2022Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
492100000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
109925000
alks Marketable Securities Realized Loss
MarketableSecuritiesRealizedLoss
977000
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
326560000
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
323341000
CY2022Q2 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
1820000
CY2022Q2 us-gaap Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
1820000
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
185980000
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
180170000
CY2022Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
512540000
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
503511000
CY2022Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
1820000
CY2022Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
1820000
alks Fair Value Recurring Basis Assets Or Liabilities Transfers Between Level One To Level Two
FairValueRecurringBasisAssetsOrLiabilitiesTransfersBetweenLevelOneToLevelTwo
0
alks Fair Value Recurring Basis Assets Or Liabilities Transfers Between Level Two To Level One
FairValueRecurringBasisAssetsOrLiabilitiesTransfersBetweenLevelTwoToLevelOne
0
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
13777000
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
23048000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
500000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
-1043000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
29000
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
4279000
CY2021 alks Milestone Payments Received
MilestonePaymentsReceived
7800000
CY2022Q2 alks Future Milestones Receivable Between2022 And2027
FutureMilestonesReceivableBetween2022And2027
38600000
CY2022Q2 alks Number Of Equal Annual Installments Milestone Payment
NumberOfEqualAnnualInstallmentsMilestonePayment
6
CY2022Q2 us-gaap Business Combination Contingent Consideration Asset
BusinessCombinationContingentConsiderationAsset
3800000
CY2021Q4 us-gaap Business Combination Contingent Consideration Asset
BusinessCombinationContingentConsiderationAsset
23000000.0
CY2022Q2 us-gaap Business Combination Contingent Consideration Asset Current
BusinessCombinationContingentConsiderationAssetCurrent
3800000
CY2021Q4 us-gaap Business Combination Contingent Consideration Asset Current
BusinessCombinationContingentConsiderationAssetCurrent
6400000
CY2022Q2 us-gaap Business Combination Contingent Consideration Asset Noncurrent
BusinessCombinationContingentConsiderationAssetNoncurrent
0
CY2021Q4 us-gaap Business Combination Contingent Consideration Asset Noncurrent
BusinessCombinationContingentConsiderationAssetNoncurrent
16600000
CY2022Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
52870000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
56125000
CY2022Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
70437000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
59105000
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
32301000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
35105000
CY2022Q2 us-gaap Inventory Net
InventoryNet
155608000
CY2021Q4 us-gaap Inventory Net
InventoryNet
150335000
CY2022Q2 alks Inventory Finished Goods Net Of Reserves Located At Third Party Warehouse And Shipping Service Provider
InventoryFinishedGoodsNetOfReservesLocatedAtThirdPartyWarehouseAndShippingServiceProvider
25700000
CY2021Q4 alks Inventory Finished Goods Net Of Reserves Located At Third Party Warehouse And Shipping Service Provider
InventoryFinishedGoodsNetOfReservesLocatedAtThirdPartyWarehouseAndShippingServiceProvider
25100000
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
752707000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
736617000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
415561000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
395563000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
337146000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
341054000
CY2022Q2 us-gaap Goodwill Gross
GoodwillGross
92873000
CY2022Q2 us-gaap Goodwill
Goodwill
92873000
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
583750000
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
527739000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
56011000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
35000000.0
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
35000000.0
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1000000.0
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
9012000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
17991000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
18206000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
17329000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
18476000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
17535000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
18750000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
17808000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
14719000
us-gaap Operating Lease Payments
OperatingLeasePayments
8900000
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
4400000
CY2022Q2 alks Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
95289000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
95229000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
174452000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
179669000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
59267000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
115776000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
120402000
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0521
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y1M6D
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
4500000
us-gaap Operating Lease Payments
OperatingLeasePayments
8100000
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
4200000
us-gaap Operating Lease Expense
OperatingLeaseExpense
8300000
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
4400000
us-gaap Operating Lease Expense
OperatingLeaseExpense
8600000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
40047000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
55721000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
52865000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
77256000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
93902000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
75514000
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
186814000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
208491000
CY2022Q2 alks Accrued Sales Discounts Allowances And Reserves
AccruedSalesDiscountsAllowancesAndReserves
228973000
CY2021Q4 alks Accrued Sales Discounts Allowances And Reserves
AccruedSalesDiscountsAllowancesAndReserves
237216000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23377000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27552000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
41720000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
43003000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
2800000
CY2021 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
2300000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-30136000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
2364000
us-gaap Net Income Loss
NetIncomeLoss
-66039000
us-gaap Net Income Loss
NetIncomeLoss
-20054000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
163839000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
160817000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
163165000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
160229000
CY2021Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3120000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
163839000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
163937000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
163165000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
160229000
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17499000
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16061000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18928000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18454000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3100000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12200000
us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
0
CY2020Q3 alks Maximum Period Before Fda Can Approve Patent Request
MaximumPeriodBeforeFDACanApprovePatentRequest
P30M
CY2022Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
245840000
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
313193000
CY2022Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
326321000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
198767000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1487000
us-gaap Interest Expense
InterestExpense
6377000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
4518000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-78248000
us-gaap Operating Income Loss
OperatingIncomeLoss
-61042000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-222000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-18197000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
97473000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
188826000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4241000
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
53124000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-17206000
us-gaap Net Income Loss
NetIncomeLoss
-66039000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
113519000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
554764000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
139188000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1234000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3291000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12209000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
2364000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
74043000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
56011000
CY2022Q2 us-gaap Long Term Investments
LongTermInvestments
179010000
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
229430000
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
123702000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
81833000
us-gaap Costs And Expenses
CostsAndExpenses
567158000
us-gaap Operating Income Loss
OperatingIncomeLoss
-12011000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-615000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-987000
CY2022Q2 us-gaap Interest Expense
InterestExpense
2369000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1469000
CY2021Q2 us-gaap Interest Expense
InterestExpense
2407000
us-gaap Net Income Loss
NetIncomeLoss
-20054000
us-gaap Net Income Loss
NetIncomeLoss
-66039000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-6765000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32390000
CY2021Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
3240000
CY2022Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
870000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1810000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20927000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-72804000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
163165000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
160229000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
163937000
us-gaap Net Income Loss
NetIncomeLoss
-20054000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
326000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-873000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2092000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-79000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2254000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-272000
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
18445000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
175499000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
150377000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1207000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3114000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
58676000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1097902000

Files In Submission

Name View Source Status
0001564590-22-026586-index-headers.html Edgar Link pending
0001564590-22-026586-index.html Edgar Link pending
0001564590-22-026586.txt Edgar Link pending
0001564590-22-026586-xbrl.zip Edgar Link pending
alks-10q_20220630.htm Edgar Link pending
alks-10q_20220630_htm.xml Edgar Link completed
alks-20220630.xsd Edgar Link pending
alks-20220630_cal.xml Edgar Link unprocessable
alks-20220630_def.xml Edgar Link unprocessable
alks-20220630_lab.xml Edgar Link unprocessable
alks-20220630_pre.xml Edgar Link unprocessable
alks-ex1011_141.htm Edgar Link pending
alks-ex1012_140.htm Edgar Link pending
alks-ex311_7.htm Edgar Link pending
alks-ex312_6.htm Edgar Link pending
alks-ex31_93.htm Edgar Link pending
alks-ex321_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gc0hekdoz133000001.jpg Edgar Link pending
gc0hekdoz133000002.jpg Edgar Link pending
gc0hekdoz133000003.jpg Edgar Link pending
gc0hekdoz133000004.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending